Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease

被引:23
作者
Martens, Fabrice M. A. C. [1 ]
van der Graaf, Yolanda [2 ]
Dijk, Joke A. [2 ]
Olijhoek, Jobien K. [1 ]
Visseren, Frank L. J. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Internal Med, Sect Vasc Med & Diabetol, NL-3508 GA Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
关键词
carotid artery stiffness; diabetes mellitus; metabolic syndrome;
D O I
10.1016/j.atherosclerosis.2007.02.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Insulin resistance is generally considered to be of major importance in the pathophysiology of the metabolic syndrome and type 2 diabetes mellitus, both high-risk conditions for cardiovascular complications. Carotid artery stiffness is increasingly recognized as an important predictor of cardiovascular morbidity and mortality. Therefore, in the present study we determined whether the metabolic syndrome (MetSyn) and type 2 diabetes mellitus (DM2) are associated with carotid artery stiffness in patients with already clinical manifestations of arterial disease. Methods and results: A cross-sectional study in 2105 patients with manifest arterial disease (cerebral, coronary or peripheral artery disease, renal artery stenosis or an aneurysm of the abdominal aorta) was performed. The difference in carotid stiffness between patients with and without MetSyn and with and without DM2 was studied with linear regression analysis. Compared to patients without DM2 (N = 1112), patients with DM2 (N = 301) had significantly higher arterial stiffness (distension -18.5 (-35. 1;-1.9) 95% CI/distensibility -1.8 (-2.2;-1.4) 95% CI). Generally, there was a trend of higher carotid stiffness in patients with MetSyn (N = 922) compared to patients without (N = 1112) MetSyn (distension -9.6 (-21.5;2.3) 95% CI/distensibility -2.0 (-2.6;-1.4) 95% CI). Excluding the patients with also DM2 (N = 230) from the MetSyn-group diminished this relation (distension -5.7 (-18.8;7.4) 95% CI/distensibility -1.1 (-1.6;-0.6) 95% CI). Furthermore, in the population as a whole, carotid artery stiffness increased with increasing number of components of the metabolic syndrome (p = 0.08 for distension/p <= 0.001 for distensibility). In addition, this association was not as clear after exclusion of the patients with DM2 from the MetSyn-group (p = 0.24 for distension/p < 0.001 for distensibility). From all the components of the MetSyn only high blood pressure and high fasting glucose influenced the carotid artery stiffness. Conclusions: We concluded that (increasing number of components of) the metabolic syndrome were associated with marginally higher carotid artery stiffness, while type 2 diabetes was associated with a marked increase in carotid artery stiffness, in patients with already clinical manifestations of arterial disease. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:646 / 653
页数:8
相关论文
共 44 条
[1]   ARTERIAL STIFFNESS - A NEW CARDIOVASCULAR RISK FACTOR [J].
ARNETT, DK ;
EVANS, GW ;
RILEY, WA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (08) :669-682
[2]   EFFECTS OF AGING ON ARTERIAL DISTENSIBILITY IN POPULATIONS WITH HIGH AND LOW PREVALENCE OF HYPERTENSION - COMPARISON BETWEEN URBAN AND RURAL COMMUNITIES IN CHINA [J].
AVOLIO, AP ;
DENG, FQ ;
LI, WQ ;
LUO, YF ;
HUANG, ZD ;
XING, LF ;
OROURKE, MF .
CIRCULATION, 1985, 71 (02) :202-210
[3]  
Baron AD, 1999, AM J CARDIOL, V84, p25J
[4]   Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: The early start of a dangerous situation [J].
Caballero, AE .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (03) :241-249
[5]   Intra-arterial tumor necrosis factor-α impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans [J].
Chia, S ;
Qadan, M ;
Newton, R ;
Ludlam, CA ;
Fox, KAA ;
Newby, DE .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (04) :695-701
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Arterial stiffness, vascular disease, and risk of cardiovascular events [J].
Cohn, JN .
CIRCULATION, 2006, 113 (05) :601-603
[8]   Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study [J].
de Vegt, F ;
Dekker, JM ;
Jager, A ;
Hienkens, E ;
Kostense, PJ ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16) :2109-2113
[9]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[10]   Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study [J].
Dijk, JM ;
Algra, A ;
van der Graaf, Y ;
Grobbee, DE ;
Bots, ML .
EUROPEAN HEART JOURNAL, 2005, 26 (12) :1213-1220